Armin Saalmüller

Title: Armin Saalmüller: Innovator in Immunogenic Peptides

Introduction

Armin Saalmüller is a notable inventor based in Reutlingen, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines for foot-and-mouth disease.

Latest Patents

Saalmüller's most recent patent focuses on immunogenic peptides of foot-and-mouth disease viruses. The invention relates to an FMDC vaccine based on peptides that have a sequence of at least 8 amino acids. These peptides correspond to a partial sequence of the non-structural protein region of FMDV. They were selected based on immunoreactivity with FMDV-specific antibodies or T lymphocytes. This innovative approach aims to enhance the effectiveness of vaccines against this viral disease.

Career Highlights

Armin Saalmüller is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on groundbreaking research and development in vaccine technology.

Collaborations

Throughout his career, Saalmüller has collaborated with esteemed colleagues, including Roberto Correa and Hans-Robert Hehnen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Armin Saalmüller stands out as an influential inventor in the field of immunogenic peptides, with a focus on enhancing vaccine efficacy against foot-and-mouth disease. His contributions continue to impact the scientific community and public health positively.